Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial

Luvira V., Schilling WHK., Jittamala P., Watson JA., Boyd S., Siripoon T., Ngamprasertchai T., Almeida PJ., Ekkapongpisit M., Cruz C., Callery JJ., Singh S., Tuntipaiboontana R., Kruabkontho V., Ngernseng T., Tubprasert J., Abdad MY., Keayarsa S., Madmanee W., Aguiar RS., Santos FM., Hanboonkunupakarn P., Hanboonkunupakarn B., Poovorawan K., Imwong M., Taylor WRJ., Chotivanich V., Chotivanich K., Pukrittayakamee S., Dondorp AM., Day NPJ., Teixeira MM., Piyaphanee W., Phumratanaprapin W., White NJ.

DOI

10.21203/rs.3.rs-2675703/v1

Type

Publication Date

05/04/2023

Permalink Original publication